This study presents fundamental insights into overcoming resistance in hormone receptor-positive breast cancer by demonstrating that sustained CDK4/6 inhibitor treatment, either alone or in ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target ...

Researchers have discovered how a particular protein affects the growth and spread of colon cancer in humans. The study not ...

A study published by the Journal of Traditional and Complementary Medicine and e-published by the U.S. National Library of ...

A research team led by Prof. WENG Jianping from the University of Science and Technology of China (USTC) of the Chinese ...

T cells play a pivotal role in the immune system by transforming into powerful effector cells that combat pathogens. This transformation requires rapid proliferation, during which DNA replication ...

The expanding oncology pipeline in the USA is a key driver for cytotoxic drug demand, with over 1,000 oncology drugs in development. Advancements in ...

EBP1 is low in Alzheimer’s disease brains, hinting at human relevance. “Our study suggests that … preservation of functional EBP1 could be a therapeutic strategy for AD,” the authors noted. The ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced its 2025 priorities and upcoming ...

The global antibody drug conjugates market size was valued at USD 11.84 billion in 2024 and is projected to reach from USD 12.89 billion in 2025 to USD 25.38 billion by 2033, growing at a CAGR of 8.84 ...

Inhibiting telomerase activity, which is increased in malignant stem and progenitor cells in the bone marrow, aims to reduce ...